Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1992-05-19
1993-11-09
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 60, 514892, A61K 31715
Patent
active
052602834
ABSTRACT:
Wheat bran fiber is used to alter the enterohepatic recirculation of estrogens leading to an increased fecal excretion of estrogens together with a decrease in urinary excretion of estrogens. Increased lipid excretion is also found. Thus wheat bran fiber is useful to remove estrogen and lipid in mammals.
REFERENCES:
National Research Council, Committe on Diet and Health. Diet and Health. Implications for Reducing Chronic Disease Risk. Washington, D.C. National Acad. Press, 1989.
Van't Veer, P., et al. Int. J. Cancer 45:825-828 (1990).
Rose, D. P., Cancer Surveys 5(3):671-687 (1986).
Lubin, F., et al. JNCI 77:605-612 (1986).
Rose, D. P., Nutrition and Cancer 13 (1 and 2):1-8 (1990).
Adlercreutz, H., et al. Proceedings of the Symposium on the Analysis of Steroids, Eger, Hungary (1981).
Adlercreutz, H., Gastroenterology 86:761-766 (1986).
Adlercreutz, H., et al. Prog. Cancer Res. Ther. 35:409-412 (1988).
Armstrong, B. K., et al. JNCI 67:761-767 (1981).
Goldin, B. R., et al. Am. J. Clin. Nutr. 44:945-953 (1986).
Goldin, B. R. et al. N. Eng. J. Med. 307:1542-1547 (1982).
Gorbach, S. L., and Goldin, B. R. Prevent. Med. 16:525-531 (1987).
Fentiman, I. S. et al. Nutr. Cancer 11:101-106 (1988).
Barbosa, J. C., et al. Am J. Clin. Nutr. 51:798-803 (1990).
Chan, P. C., et al. JNCI 59:1279-1283 (1977).
Bieri, J. G., et al. J. Nutr. 107:1340-1348 (1977).
Kohigashi, K., et al. Jpn. J. Cancer Res. (Gann) 79:1335-1339 (1988).
Fotsis T., and Adlercreutz, H. J. Steroid Biochem. 28(2):203-213 (1987).
Shultz, T. D. and Howie, B. J. Cancer 8:141-147 (1986).
Porter, L. E., et al. Gastroenter. 84:704-712 (1984).
Aten, R. F., et al. Endocrinol. 131:1629-1635 (1978).
Powell-Jones, W., et al. J. Steroid Biochem. 13:219-229 (1980).
Southgate, D.A.T., and Durnin, J.V.G.A. Brit. J. Nutr. 24: 517-535 (1970).
24. Kelsay, J. L., et al., Am. J. Clin. Nutr. 31:1149-1153 (1978).
Heber, David et al. (Mar./Apr. 1991) Nutrition 7:137.
Cohen, L. A., et al. J. Natl. Cancer Inst. (1991) 83:496.
Rose, David P. Am. J. Clin. Nutr. (1991) 54:520-5.
Arts, Cor J. M., J. Steroid Biochem. Molec. Biol. (Aug. 30, 1991) 39:193-202.
Cohen, L. A. et al. (Abstract) Presented Poster session Oct. 1990.
Woods, Margo N. Am. J. Clin. Nutr. (1989) 49:1179-83.
Kendall, M. E., et al. 73rd Annual Endocrine Society Meeting Washington, D.C. published May 20, 1991.
Cohen Leonard A.
Kendall Marcia E.
American Health Foundation
Rollins John W.
LandOfFree
Method for altering excretion of estrogens or lipids in mammals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for altering excretion of estrogens or lipids in mammals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for altering excretion of estrogens or lipids in mammals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1142814